1. Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. Issue 2 (28th January 2020) Authors: Siddiqi, Tanya; Frankel, Paul; Beumer, Jan H.; Kiesel, Brian F.; Christner, Susan; Ruel, Chris; Song, Joo Y.; Chen, Robert; Kelly, Kevin R.; Ailawadhi, Sikander; Kaesberg, Paul; Popplewell, Leslie; Puverel, Sandrine; Piekarz, Richard; Forman, Stephen J.; Newman, Edward M. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 2(2020) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗